Wan X, Wang T, Yang J, Yang X, Li W, Ding L, Yang L, Zhang J, Su M, An K, Zhou Z, Li Y, Wang X, Zhu H, Luo C, Gu L, Chen J, Song L, Tang Y, Li B. Durable remission achieved in pediatric patients with TCF3-HLF-positive relapsed/refractory B-cell acute lymphoblastic leukemia by dual CD19- and CD22-targeted chimeric antigen receptor T-cell therapy. haematol [Internet]. 2026Jan.1 [cited 2026Mar.25];111(1):340-4. Available from: https://haematologica.org/article/view/12070